A Multi-enter, Randomized, Double-blind, Placebo-controlled, Four-way Incomplete Block Crossover Study to Examine Efficacy, Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of Single and Repeat Administration of Three Inhaled Doses (10, 15, and 20 Mcg) of GSK159797
Phase of Trial: Phase II
Latest Information Update: 03 Nov 2016
At a glance
- Drugs Milveterol (Primary) ; Salmeterol
- Indications Asthma
- Focus Therapeutic Use
- Sponsors GlaxoSmithKline
- 13 Oct 2008 Trial centre added and phase ammended as reported by ClinicalTrials.gov.
- 02 Apr 2007 Status changed from recruiting to completed.
- 04 Nov 2006 New trial record.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History